drugset / Trial / NCT04663464
Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women.
RandomizedCrossoverOpen-labelTreatment
Summary
A study to evaluate and compare the PK profiles of abaloparatide-SC 80 μg and abaloparatide-sMTS 300 μg in a cohort of healthy men and to make a similar evaluation in a cohort of healthy women
Timeline
- Start
- 2020-11-16
- Primary completion
- 2021-03-27
- Completion
- 2021-11-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abaloparatide | Peptide | 80 ug | Subcutaneous |
| Subject | Abaloparatide | Peptide | 300 ug | Subcutaneous |
Indications
No indication recorded.